Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
ING Group ADR | ING | 8. oct 2024 | 17.64 | -0.11 |
Ingersoll Rand | IR | 8. oct 2024 | 98.87 | -1.15 |
Ingevity | NGVT | 8. oct 2024 | 34.54 | -3.76 |
Ingles Markets A | IMKTA | 8. oct 2024 | 61.50 | +1.07 |
Ingredion | INGR | 8. oct 2024 | 134.03 | -0.34 |
Inhibikase Therapeutics | IKT | 8. oct 2024 | 1.19 | -4.80 |
Inhibrx Biosciences | INBX | 8. oct 2024 | 15.99 | +4.72 |
InMed | INM | 8. oct 2024 | 0.21 | -3.02 |
InMode | INMD | 8. oct 2024 | 14.88 | -1.52 |
INmune Bio | INMB | 8. oct 2024 | 5.31 | +1.34 |
Innate Pharma ADR | IPHA | 8. oct 2024 | 2.14 | +3.88 |
Inno Holdings | INHD | 8. oct 2024 | 0.56 | +1.85 |
Innodata | INOD | 8. oct 2024 | 15.52 | +0.45 |
Innospec | IOSP | 8. oct 2024 | 110.89 | -0.19 |
InnovAge | INNV | 8. oct 2024 | 5.44 | +1.68 |
Innovate | VATE | 8. oct 2024 | 3.86 | +5.75 |
Innovation Beverage Group | IBG | 8. oct 2024 | 1.61 | 0.00 |
Innovative Eyewear | LUCY | 8. oct 2024 | 7.80 | +0.52 |
Innovative Industrial Properties | IIPR | 8. oct 2024 | 129.51 | +0.09 |
Innovative Industrial Properties A Pref | IIPR-A | 8. oct 2024 | 26.08 | +0.31 |
Innovative Solutions and Support | ISSC | 8. oct 2024 | 6.89 | +2.84 |
Innovex International | INVX | 8. oct 2024 | 15.01 | 0.00 |
Innovid | CTV | 8. oct 2024 | 1.75 | +2.34 |
Innoviva | INVA | 8. oct 2024 | 19.83 | +0.46 |
Innoviz Technologies | INVZ | 8. oct 2024 | 0.81 | -2.29 |
InnSuites Hospitality | IHT | 8. oct 2024 | 1.93 | +6.63 |
Innventure | INV | 8. oct 2024 | 10.30 | 0.00 |
Inogen | INGN | 8. oct 2024 | 9.19 | +0.33 |
Inotiv | NOTV | 8. oct 2024 | 1.84 | -0.54 |
Inovio Pharmaceuticals | INO | 8. oct 2024 | 5.69 | +6.75 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.